DK has been the subject of a number of other reports. Raymond James decreased their target price on Delek US from $46.00 to $45.00 and set a strong-buy rating for the company in a research report on Wednesday, April 10th. Barclays reissued a buy rating and issued a $51.00 target price on shares of Delek US in a research report on Thursday, February 21st. Goldman Sachs Group cut Delek US from a buy rating to a neutral rating and decreased their target price for the company from $44.00 to $42.00 in a research report on Tuesday, April 16th. Finally, Mizuho reissued a buy rating and issued a $60.00 target price on shares of Delek US in a research report on Thursday, February 21st. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. Delek US currently has an average rating of Hold and an average target price of $47.24.
NYSE:DK opened at $38.06 on Monday. The stock has a market cap of $2.83 billion, a PE ratio of 7.93 and a beta of 1.41. Delek US has a 1 year low of $29.51 and a 1 year high of $56.36. The company has a quick ratio of 1.00, a current ratio of 1.48 and a debt-to-equity ratio of 0.99.
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 3rd. Shareholders of record on Monday, June 3rd were paid a dividend of $0.28 per share. The ex-dividend date was Friday, May 31st. This is an increase from Delek US’s previous quarterly dividend of $0.27. This represents a $1.12 annualized dividend and a yield of 2.94%. Delek US’s dividend payout ratio is currently 23.33%.
In other Delek US news, CFO Assi Ginzburg sold 10,478 shares of the company’s stock in a transaction that occurred on Friday, April 5th. The stock was sold at an average price of $38.95, for a total transaction of $408,118.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.20% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of DK. Clal Insurance Enterprises Holdings Ltd increased its stake in Delek US by 38.1% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,049,314 shares of the oil and gas company’s stock valued at $38,216,000 after purchasing an additional 289,314 shares in the last quarter. Menora Mivtachim Holdings LTD. increased its stake in Delek US by 2.5% in the 1st quarter. Menora Mivtachim Holdings LTD. now owns 3,788,981 shares of the oil and gas company’s stock valued at $137,995,000 after purchasing an additional 92,311 shares in the last quarter. Kennedy Capital Management Inc. increased its stake in Delek US by 100.6% in the 1st quarter. Kennedy Capital Management Inc. now owns 249,680 shares of the oil and gas company’s stock valued at $9,093,000 after purchasing an additional 125,227 shares in the last quarter. OppenheimerFunds Inc. increased its stake in Delek US by 132.3% in the 1st quarter. OppenheimerFunds Inc. now owns 417,745 shares of the oil and gas company’s stock valued at $15,214,000 after purchasing an additional 237,884 shares in the last quarter. Finally, Delek Group Ltd. increased its stake in Delek US by 8.1% in the 1st quarter. Delek Group Ltd. now owns 938,721 shares of the oil and gas company’s stock valued at $34,020,000 after purchasing an additional 70,686 shares in the last quarter.
Delek US Company Profile
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company's Refining segment processes crude oil and other purchased feedstocks for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminals.
Recommended Story: What causes a recession?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.